Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy

SIMPLE SUMMARY: Immunotherapy in the form of Immune Checkpoint Inhibitors which currently represent one of the staples of advanced Non-Small Cell Lung Cancer treatment. However, as of today, no prognostic factors are taken in account to shape immunotherapy-treated patient selection and management ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocco, Danilo, Della Gravara, Luigi, Ragone, Angela, Sapio, Luigi, Naviglio, Silvio, Gridelli, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571734/
https://www.ncbi.nlm.nih.gov/pubmed/37835378
http://dx.doi.org/10.3390/cancers15194684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571734/
https://www.ncbi.nlm.nih.gov/pubmed/37835378
http://dx.doi.org/10.3390/cancers15194684

Ejemplares similares